Cargando…
Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo
BACKGROUND: Pancreatic cancer (PC) stands out as one of the most lethal cancers. Due to late diagnosis, only a fraction of patients can be resected. Although it still has significant adverse effects and poor results, the treatment is connected with better overall survival than the prior treatment. T...
Autores principales: | Jie, Zhang, Jinna, Zhang, Jingjun, Zhang, Pengcheng, Li, Fang, Yang, Qinyang, Chen, Taiyu, Chen, Hequn, Jiang, Tao, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970865/ https://www.ncbi.nlm.nih.gov/pubmed/35368919 http://dx.doi.org/10.1155/2022/1620802 |
Ejemplares similares
-
Retracted: Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo
por: Healthcare Engineering, Journal of
Publicado: (2023) -
10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells
por: MU, QITIAN, et al.
Publicado: (2014) -
Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo
por: Chen, Tao, et al.
Publicado: (2021) -
Antitumor Efficacy of α-Solanine against Pancreatic Cancer In Vitro and In Vivo
por: Lv, Chongqing, et al.
Publicado: (2014) -
TB-4 Antitumor effects of a novel curcumin derivative curcumin monoglucuronide on glioblastoma cells in vitro and in vivo
por: Fujii, Takashi, et al.
Publicado: (2021)